成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

  1. Cell Cycle/DNA Damage Cytoskeleton Autophagy
  2. Microtubule/Tubulin Autophagy
  3. Vinblastine sulfate

Vinblastine sulfate  (Synonyms: 硫酸長(zhǎng)春堿; Vincaleukoblastine sulfate salt)

目錄號(hào): HY-13780 純度: 99.86%
COA 產(chǎn)品使用指南

Vinblastine sulfate是一種針對(duì)各種癌癥類(lèi)型的有細(xì)胞毒性的生物堿。 長(zhǎng)春花堿可抑制微管的形成,抑制nAChR的IC50值為8.9 μM。

MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)

Vinblastine sulfate Chemical Structure

Vinblastine sulfate Chemical Structure

CAS No. : 143-67-9

1.  客戶(hù)無(wú)需承擔(dān)相應(yīng)的運(yùn)輸費(fèi)用。

2.  同一機(jī)構(gòu)(單位)同一產(chǎn)品試用裝僅限申領(lǐng)一次,同一機(jī)構(gòu)(單位)一年內(nèi)

     可免費(fèi)申領(lǐng)三個(gè)不同產(chǎn)品的試用裝。

3.  試用裝只面向終端客戶(hù)

規(guī)格 價(jià)格 是否有貨 數(shù)量
10 mM * 1 mL in DMSO ¥765
In-stock
1 mg ¥234
In-stock
5 mg ¥515
In-stock
10 mg ¥770
In-stock
50 mg ¥2640
In-stock
100 mg ¥4200
In-stock
200 mg   詢(xún)價(jià)  
500 mg   詢(xún)價(jià)  

* Please select Quantity before adding items.

Customer Review

Other Forms of Vinblastine sulfate:

  • 生物活性

  • 純度 & 產(chǎn)品資料

  • 參考文獻(xiàn)

生物活性

Vinblastine sulfate is a cytotoxic alkaloid used against various cancer types. Vinblastine sulfate inhibits the formation of microtubule and suppresses nAChR with an IC50 of 8.9 μM.

IC50 & Target

IC50: 8.9 μM(nAChR)[1]

細(xì)胞效力
(Cellular Effect)
Cell Line Type Value Description References
A-375 IC50
7.2 μM
Compound: Vinblastine sulfate
Cytotoxicity against human A375 cells after 48 hrs by SRB assay
Cytotoxicity against human A375 cells after 48 hrs by SRB assay
[PMID: 19467877]
A549 IC50
2.36 μM
Compound: Vinblastine sulphate
Antiproliferative activity against human A549 cells after 48 hrs by MTS assay
Antiproliferative activity against human A549 cells after 48 hrs by MTS assay
[PMID: 22546674]
A549 IC50
67.3 μM
Compound: Vinblastine sulfate
Cytotoxicity against human A549 cells after 48 hrs by SRB assay
Cytotoxicity against human A549 cells after 48 hrs by SRB assay
[PMID: 19467877]
ACHN IC50
22.7 μM
Compound: Vinblastine sulfate
Cytotoxicity against human ACHN cells after 48 hrs by SRB assay
Cytotoxicity against human ACHN cells after 48 hrs by SRB assay
[PMID: 19467877]
BXPC-3 IC50
1.13 μM
Compound: Vinblastine sulphate
Antiproliferative activity against human BxPC3 cells after 48 hrs by MTS assay
Antiproliferative activity against human BxPC3 cells after 48 hrs by MTS assay
[PMID: 22546674]
C32 IC50
3 μM
Compound: Vinblastine sulfate
Cytotoxicity against human C32 cells after 48 hrs by SRB assay
Cytotoxicity against human C32 cells after 48 hrs by SRB assay
[PMID: 19467877]
Caco-2 IC50
69 μM
Compound: Vinblastine sulfate
Cytotoxicity against human Caco-2 cells after 48 hrs by SRB assay
Cytotoxicity against human Caco-2 cells after 48 hrs by SRB assay
[PMID: 19467877]
COR-L23 IC50
45.5 μM
Compound: Vinblastine sulfate
Cytotoxicity against human COR-L23 cells after 48 hrs by SRB assay
Cytotoxicity against human COR-L23 cells after 48 hrs by SRB assay
[PMID: 19467877]
DU-145 IC50
4.25 μM
Compound: Vinblastine sulphate
Antiproliferative activity against human DU145 cells after 48 hrs by MTS assay
Antiproliferative activity against human DU145 cells after 48 hrs by MTS assay
[PMID: 22546674]
HepG2 IC50
0.019 μM
Compound: Vinblastine sulfate
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay
[PMID: 23708010]
HepG2 IC50
0.056 μM
Compound: Vinblastine sulfate
Cytotoxicity against adriamycin-resistant human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against adriamycin-resistant human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay
[PMID: 23708010]
HepG2 IC50
0.16 μM
Compound: Vinblastine sulphate
Antiproliferative activity against human HepG2 cells after 48 hrs by MTS assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTS assay
[PMID: 22546674]
HT-29 IC50
0.55 μM
Compound: Vinblastine
Cytotoxicity against human HT-29 cells after 48 hrs by MTS assay
Cytotoxicity against human HT-29 cells after 48 hrs by MTS assay
[PMID: 21920762]
HT-29 IC50
11.18 μM
Compound: Vinblastine sulphate
Antiproliferative activity against human HT-29 cells after 48 hrs by MTS assay
Antiproliferative activity against human HT-29 cells after 48 hrs by MTS assay
[PMID: 22546674]
K562 IC50
0.001 μM
Compound: Vinblastine sulphate
Antiproliferative activity against human K562 cells after 48 hrs by hemocytometer
Antiproliferative activity against human K562 cells after 48 hrs by hemocytometer
[PMID: 21705223]
K562 IC50
0.001 μM
Compound: vinblastine sulfate
Antiproliferative activity against human K562 cells after 48 hrs by hemocytometric analysis
Antiproliferative activity against human K562 cells after 48 hrs by hemocytometric analysis
[PMID: 21563750]
K562 IC50
0.001 μM
Compound: 1
Cell growth inhibition of human K562 cells after 48 hrs
Cell growth inhibition of human K562 cells after 48 hrs
[PMID: 20546980]
K562 IC50
0.001 μM
Compound: 1
Antiproliferative activity against human K562 cells after 48 hrs
Antiproliferative activity against human K562 cells after 48 hrs
[PMID: 20537765]
K562 IC50
0.001 μM
Compound: vinblastine sulfate
Antiproliferative activity against human K562 cells after 48 hrs
Antiproliferative activity against human K562 cells after 48 hrs
[PMID: 19220018]
K562 IC50
0.001 μM
Compound: vinblastine sulfate
Antiproliferative activity against human K562 cells after 48 hrs
Antiproliferative activity against human K562 cells after 48 hrs
[PMID: 17973361]
K562 IC50
0.016 μM
Compound: Vinblastine sulfate
Cytotoxicity against human K562 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human K562 cells assessed as growth inhibition after 72 hrs by MTT assay
[PMID: 23708010]
L6 ED50
6.1 μM
Compound: vinblastine sulphate
Cytotoxicity against human SCL6 cells by MTT assay
Cytotoxicity against human SCL6 cells by MTT assay
[PMID: 12880314]
LNCaP IC50
29.3 μM
Compound: Vinblastine sulfate
Cytotoxicity against human LNCAP cells after 48 hrs by SRB assay
Cytotoxicity against human LNCAP cells after 48 hrs by SRB assay
[PMID: 19467877]
MCF7 IC50
0.007 μM
Compound: Vinblastine sulfate
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay
[PMID: 23708010]
MCF7 IC50
24.08 μM
Compound: Vinblastine sulphate
Antiproliferative activity against human MCF7 cells after 48 hrs by MTS assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTS assay
[PMID: 22546674]
MDA-MB-231 IC50
0.0083 μM
Compound: Vinblastine sulfate
Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs by MTT assay
[PMID: 23708010]
MDA-MB-231 IC50
31.52 μM
Compound: Vinblastine sulphate
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTS assay
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTS assay
[PMID: 22546674]
NUGC-4 ED50
5.3 μM
Compound: vinblastine sulphate
Cytotoxicity against human NUGC4 cells by MTT assay
Cytotoxicity against human NUGC4 cells by MTT assay
[PMID: 12880314]
SK-MEL-5 IC50
1.74 μM
Compound: Vinblastine sulphate
Antiproliferative activity against human SK-MEL-5 cells after 48 hrs by MTS assay
Antiproliferative activity against human SK-MEL-5 cells after 48 hrs by MTS assay
[PMID: 22546674]
UACC-903 IC50
1.65 μM
Compound: Vinblastine
Cytotoxicity against human UACC903 cells after 48 hrs by MTS assay
Cytotoxicity against human UACC903 cells after 48 hrs by MTS assay
[PMID: 21920762]
體外研究
(In Vitro)

Vinblastine does not depolymerize spindle microtubules, yet it powerfully blocks mitosis (for example, IC50 0.8 nM in HeLa cells) and cells die by apoptosis[2]. In NB4 cells, vinblastine produces alteration of p53 and DNA fragmentation. Vinblastine treatment has an antiproliferative effect via the induction of apoptosis producing Bax/Bcl-2 imbalance. Vinblastine treatment suppresses NFκB expression and depresses NFκB-DNA binding activity while maintaining JNK activation that subsequently results in apoptotic response through caspase-dependent pathway[3]. Vinblastine is found to trigger apoptosis as evidenced by the loss of mitochondrial membrane potential, the release of both cytochrome c and apoptosis inducing factor, activation of caspase-9 and 3, and cleavage of Poly (ADP-ribose)-Polymerase[4].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

體內(nèi)研究
(In Vivo)

Vinblastine is a widely used anticancer drug with undesired side effects. Its conjugation with carrier molecules could be an efficient strategy to reduce these side effects[5].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Clinical Trial
分子量

909.05

Formula

C46H60N4O13S

CAS 號(hào)
性狀

固體

顏色

White to off-white

中文名稱(chēng)

硫酸長(zhǎng)春堿

結(jié)構(gòu)分類(lèi)
初始來(lái)源
運(yùn)輸條件

Room temperature in continental US; may vary elsewhere.

儲(chǔ)存方式

4°C, sealed storage, away from moisture and light

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

溶解性數(shù)據(jù)
細(xì)胞實(shí)驗(yàn): 

H2O 中的溶解度 : 50 mg/mL (55.00 mM; 超聲助溶)

DMSO 中的溶解度 : ≥ 44 mg/mL (48.40 mM; 吸濕的 DMSO 對(duì)產(chǎn)品的溶解度有顯著影響,請(qǐng)使用新開(kāi)封的 DMSO)

* "≥" means soluble, but saturation unknown.

配制儲(chǔ)備液
濃度 溶劑體積 質(zhì)量 1 mg 5 mg 10 mg
1 mM 1.1000 mL 5.5002 mL 11.0005 mL
5 mM 0.2200 mL 1.1000 mL 2.2001 mL
查看完整儲(chǔ)備液配制表

* 請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;一旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效
儲(chǔ)備液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)。-80°C儲(chǔ)存時(shí),請(qǐng)?jiān)?個(gè)月內(nèi)使用,-20°C儲(chǔ)存時(shí),請(qǐng)?jiān)?個(gè)月內(nèi)使用。

* 備注:如您選擇水作為儲(chǔ)備液,請(qǐng)稀釋至工作液后,再用 0.22 μm 的濾膜過(guò)濾除菌后使用。

  • 摩爾計(jì)算器

  • 稀釋計(jì)算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質(zhì)量
=
濃度
×
體積
×
分子量 *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

濃度 (start)

C1

×
體積 (start)

V1

=
濃度 (final)

C2

×
體積 (final)

V2

動(dòng)物實(shí)驗(yàn):

請(qǐng)根據(jù)您的 實(shí)驗(yàn)動(dòng)物和給藥方式 選擇適當(dāng)?shù)娜芙夥桨浮?

以下溶解方案都請(qǐng)先按照 In Vitro 方式配制澄清的儲(chǔ)備液,再依次添加助溶劑:
——為保證實(shí)驗(yàn)結(jié)果的可靠性,澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;體內(nèi)實(shí)驗(yàn)的工作液,建議您現(xiàn)用現(xiàn)配,當(dāng)天使用
以下溶劑前顯示的百分比是指該溶劑在您配制終溶液中的體積占比;如在配制過(guò)程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過(guò)加熱和/或超聲的方式助溶

  • 方案 一

    請(qǐng)依序添加每種溶劑: 10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.5 mg/mL (2.75 mM); 澄清溶液

    此方案可獲得 ≥ 2.5 mg/mL(飽和度未知)的澄清溶液。

    1 mL 工作液為例,取 100 μL 25.0 mg/mL 的澄清 DMSO 儲(chǔ)備液加到 400 μL PEG300 中,混合均勻;再向上述體系中加入 50 μL Tween-80,混合均勻;然后再繼續(xù)加入 450 μL 生理鹽水 定容至 1 mL。

    生理鹽水的配制:將 0.9 g 氯化鈉,溶解于 ddH?O 并定容至 100 mL,可以得到澄清透明的生理鹽水溶液。
  • 方案 二

    請(qǐng)依序添加每種溶劑: 10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.5 mg/mL (2.75 mM); 澄清溶液

    此方案可獲得 ≥ 2.5 mg/mL(飽和度未知)的澄清溶液。

    1 mL 工作液為例,取 100 μL 25.0 mg/mL 的澄清 DMSO 儲(chǔ)備液加到 900 μL 20% 的 SBE-β-CD 生理鹽水水溶液 中,混合均勻。

    2 g SBE-β-CD(磺丁基醚 β-環(huán)糊精)粉末定容于 10 mL 的生理鹽水中,完全溶解至澄清透明。

以下溶解方案,請(qǐng)直接配制工作液。建議現(xiàn)用現(xiàn)配,在短期內(nèi)盡快用完。 以下溶劑前顯示的百分比是指該溶劑在您配制終溶液中的體積占比; 如在配制過(guò)程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過(guò)加熱和/或超聲的方式助溶。

  • 方案 一

    請(qǐng)依序添加每種溶劑: PBS

    Solubility: 50 mg/mL (55.00 mM); 澄清溶液; 超聲助溶

動(dòng)物溶解方案計(jì)算器
請(qǐng)輸入動(dòng)物實(shí)驗(yàn)的基本信息:

給藥劑量

mg/kg

動(dòng)物的平均體重

g

每只動(dòng)物的給藥體積

μL

動(dòng)物數(shù)量

由于實(shí)驗(yàn)過(guò)程有損耗,建議您多配一只動(dòng)物的量
計(jì)算結(jié)果
工作液所需濃度 : mg/mL
該產(chǎn)品水溶性佳,請(qǐng)具體參考實(shí)測(cè) 水 / PBS / Saline 中的溶解度數(shù)據(jù)。
您所需的儲(chǔ)備液濃度超過(guò)該產(chǎn)品的實(shí)測(cè)溶解度,如有需要,請(qǐng)與 MCE 中國(guó)技術(shù)支持聯(lián)系。
純度 & 產(chǎn)品資料

純度: 99.86%

參考文獻(xiàn)

完整儲(chǔ)備液配制表

* 請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;一旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。
儲(chǔ)備液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)。-80°C儲(chǔ)存時(shí),請(qǐng)?jiān)?個(gè)月內(nèi)使用,-20°C儲(chǔ)存時(shí),請(qǐng)?jiān)?個(gè)月內(nèi)使用。

可選溶劑 濃度 溶劑體積 質(zhì)量 1 mg 5 mg 10 mg 25 mg
DMSO / H2O 1 mM 1.1000 mL 5.5002 mL 11.0005 mL 27.5012 mL
5 mM 0.2200 mL 1.1000 mL 2.2001 mL 5.5002 mL
10 mM 0.1100 mL 0.5500 mL 1.1000 mL 2.7501 mL
15 mM 0.0733 mL 0.3667 mL 0.7334 mL 1.8334 mL
20 mM 0.0550 mL 0.2750 mL 0.5500 mL 1.3751 mL
25 mM 0.0440 mL 0.2200 mL 0.4400 mL 1.1000 mL
30 mM 0.0367 mL 0.1833 mL 0.3667 mL 0.9167 mL
40 mM 0.0275 mL 0.1375 mL 0.2750 mL 0.6875 mL
H2O 50 mM 0.0220 mL 0.1100 mL 0.2200 mL 0.5500 mL

* 備注:如您選擇水作為儲(chǔ)備液,請(qǐng)稀釋至工作液后,再用 0.22 μm 的濾膜過(guò)濾除菌后使用。

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的產(chǎn)品:

Your information is safe with us. * Required Fields.

   產(chǎn)品名稱(chēng):

 

* 需求量:

* 客戶(hù)姓名:

 

* Email:

* 電話(huà):

 

* 公司或機(jī)構(gòu)名稱(chēng):

   留言給我們:

Bulk Inquiry

Inquiry Information

產(chǎn)品名稱(chēng):
Vinblastine sulfate
目錄號(hào):
HY-13780
需求量: